Kathy Wong is an editor at Endpoints News. She co-handles Endpoints' Peer Review column, focusing on industry news related to new hirings and transitions. Kathy's work has been featured in Environmental Health News and Endpoints News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Not enough data
Kathy Wong's coverage primarily focuses on private sector announcements, particularly CEO changes and leadership transitions within the healthcare, pharmaceutical, and biotechnology sectors. Her articles often include press releases and expert commentary.
For effective outreach to Kathy Wong, consider providing insights or analysis from authoritative figures in the healthcare or biotech industry relating to CEO changes, strategic realignments, or significant personnel shifts within pharmaceutical companies. Sources with expertise in medical research and business strategy could also be valuable for her coverage.
Given the emphasis on private sector announcements in her articles, pitches related to major developments such as mergers & acquisitions or innovative breakthroughs within the pharmaceutical industry may also align well with her reporting interests.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Alex Hoffman, Lei Lei Wu, Kathy Wong
→ Boehringer Ingelheim has promoted Vani Manja to global head of the obesity and liver health therapeutic area, according to her LinkedIn. Manja came to Boehringer from medtech giant ...
By: Alex Hoffman, Kathy Wong
→ In addition to the hullabaloo surrounding its board of directors, Novo Nordisk has filled a crucial role as it wrestles with President Donald Trump …
By: Alex Hoffman, Kathy Wong
→ Megan McGill has replaced David Lucchino as CEO of Brenig Therapeutics, an OrbiMed-backed neuro biotech that collected a $65 million Series A ...
By: Kathy Wong, Kyle Lahucik, Alex Hoffman
While Novo reveals more high-level departures, Pfizer welcomes the former CSO of Blueprint Medicines.
By: Alex Hoffman, Kathy Wong
→ In what appears to be another blow to Novo Nordisk , ex- Pfizer CSO Mikael Dolsten has withdrawn his nomination
By: Alex Hoffman, Kathy Wong
Endpoints News sat down with Jeff Bluestone and Stephen Dilly after Sonoma Biotherapeutics announced earlier this week that Bluestone was stepping down …
By: Alex Hoffman, Kathy Wong
→ Altimmune CEO Vipin Garg will pass the baton to chairman Jerry Durso on Jan. 1. Durso has been a member …
By: Kathy Wong, Alex Hoffman
→ Centessa Pharmaceuticals president Mario Alberto Accardi will take over as CEO on Jan. 1. Saurabh Saha has held the …
By: Kathy Wong, Elizabeth Cairns, Alex Hoffman
→ As Viking Therapeutics shareholders wait with poorly-concealed impatience for a buyer to emerge, the obesity and MASH-focused biotech has
By: Kathy Wong, Alex Hoffman
→ Srishti Gupta took over as CEO of Idorsia last summer, but the job is open again as chairman Jean-Paul Clozel kicks …
